We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Social Adaptation in Long Term Survivors of Blood and Marrow Transplantation

This study is ongoing, but not recruiting participants.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01165788
First Posted: July 20, 2010
Last Update Posted: September 23, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Stanford University
  Purpose
  1. To explore specific aspects of social adaptation such as social connectedness, occupational outcomes and family relationships in lymphoma patients after autologous blood or marrow transplantation (BMT).
  2. To investigate how social adaptation varies with time lapsed since BMT and with the life stage as determined by patient?s age. Understanding both the positive and negative aspects of cancer and cancer therapy leads to opportunities to promote adaptive strategies.

Condition Intervention
Social Adaptation Procedure: Semi structured personal interview

Study Type: Observational
Study Design: Observational Model: Family-Based
Time Perspective: Retrospective
Official Title: Social Adaptation in Long Term Survivors of Blood and Marrow Transplantation

Resource links provided by NLM:


Further study details as provided by Stanford University:

Primary Outcome Measures:
  • Specific aspects of social adaptation, such as social connectedness, occupational outcomes and family relationships in lymphoma patients after autologous blood or marrow transplantation (BMT) [ Time Frame: 1 year ]
  • Social adaptation variation with time lapsed since BMT and with the life stage as determined by patient's age [ Time Frame: 1 year ]

Enrollment: 50
Study Start Date: November 2009
Primary Completion Date: November 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
autologous BMT recipients
Lymphoma patients who received an autologous BMT as adults
Procedure: Semi structured personal interview
A trained research assistant will conduct in-person, in-depth semi-structured interviews at a location of the participants choosing. Participants will be asked to discuss their experiences with cancer, focusing especially on how their cancer affected their (1) work/education (2) relationships with their family (spouse, children, parents, siblings and other relatives) (3) their other social relationships

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Subjects will be identified from the comprehensive database of the Blood and Marrow Transplant Division of Stanford Hospitals & Clinics. We will target lymphoma patients who received an autologous BMT as adults (18 years or older). We estimate there are ~580 surviving who are between 2 and 22 years post-BMT.
Criteria

Inclusion Criteria:

  1. Lymphoma patients treated with blood and marrow transplantation at Stanford University Medical Center
  2. Age > 18 years at the time of transplant
  3. English speaking
  4. Willingness to sign a written informed consent document
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01165788


Locations
United States, California
Stanford University School of Medicine
Stanford, California, United States, 94305
Sponsors and Collaborators
Stanford University
Investigators
Principal Investigator: Karen Cook Stanford University
Principal Investigator: Kate Tierney Stanford University
  More Information

Responsible Party: Stanford University
ClinicalTrials.gov Identifier: NCT01165788     History of Changes
Other Study ID Numbers: BMT216
SU-07092010-6496 ( Other Identifier: Stanford University )
First Submitted: July 16, 2010
First Posted: July 20, 2010
Last Update Posted: September 23, 2016
Last Verified: September 2016

Keywords provided by Stanford University:
Blood and Marrow Transplant (BMT)